Ignite Creation Date:
2024-05-06 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05322720
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-04-12
First Post:
2022-03-10
Brief Title:
HR Positive HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Sponsor:
Organization:
Taizhou EOC Pharma Co Ltd